• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Ostermann Douglas R

    4/6/26 9:04:41 PM ET
    $VGNT
    Get the next $VGNT alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Ostermann Douglas R

    (Last)(First)(Middle)
    SPITALSTRASSE 5

    (Street)
    SCHAFFHAUSEN8200

    (City)(State)(Zip)

    SWITZERLAND

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Versigent PLC [ VGNT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    Chief Financial Officer
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    04/02/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Ordinary shares, par value $0.01 per share04/02/2026(1)(2)A126,104(3)A(3)126,104(4)D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. On April 1, 2026 (the "Distribution Date"), Aptiv PLC ("Aptiv") completed a distribution of all of the ordinary shares, par value $0.01 per share, of the Issuer ("Issuer Ordinary Shares") to holders of ordinary shares of Aptiv ("Aptiv Ordinary Shares") on a pro rata basis (the "Distribution").
    2. Under the Employee Matters Agreement, dated March 30, 2026, between Aptiv and Issuer, and the Aptiv Long-Term Incentive Plan (the "LTIP"), each restricted stock unit award with respect to Aptiv Ordinary Shares granted by Aptiv under the LTIP prior to the Distribution Date (each, an "Aptiv RSU Award") was equitably adjusted and converted into a restricted stock unit award with respect to Issuer Ordinary Shares (each, an "Issuer RSU Award"), based on (I) the number of Aptiv Ordinary Shares underlying the Aptiv RSU Award immediately prior to the Distribution and (II) a fraction, the numerator of which is (A) the closing price of an Aptiv Ordinary Share on the New York Stock Exchange ("NYSE") on the trading day immediately after the Distribution Date, and (B) the denominator of which is the two-day volume-weighted average price of an Issuer Ordinary Share on the NYSE during the first and second trading days immediately after the Distribution (the "Award Conversion").
    3. Represents Issuer RSU Awards upon the conversion of certain Aptiv RSU Awards held by the Reporting Person as of immediately prior to the Distribution pursuant to the Award Conversion. The Issuer RSU Awards are subject to the terms of the Versigent PLC 2026 Long-Term Incentive Plan and are generally subject to substantially the same terms, vesting conditions and other restrictions as applicable to the related Aptiv RSU Award as of immediately prior to the Distribution.
    4. This amount includes Issuer Ordinary Shares received by the Reporting Person in connection with the Distribution.
    /s/ Janis Acosta, attorney-in-fact for Douglas R. Ostermann04/06/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $VGNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VGNT

    DatePrice TargetRatingAnalyst
    4/21/2026$55.00Outperform
    Evercore ISI
    4/14/2026$47.00Buy
    TD Cowen
    4/14/2026$43.00Buy
    UBS
    4/6/2026$35.00Overweight
    Wells Fargo
    More analyst ratings

    $VGNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI initiated coverage on Versigent with a new price target

    Evercore ISI initiated coverage of Versigent with a rating of Outperform and set a new price target of $55.00

    4/21/26 8:06:36 AM ET
    $VGNT

    TD Cowen initiated coverage on Versigent with a new price target

    TD Cowen initiated coverage of Versigent with a rating of Buy and set a new price target of $47.00

    4/14/26 9:28:32 AM ET
    $VGNT

    UBS initiated coverage on Versigent with a new price target

    UBS initiated coverage of Versigent with a rating of Buy and set a new price target of $43.00

    4/14/26 8:36:07 AM ET
    $VGNT

    $VGNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Versigent Announces First Quarter 2026 Earnings Call and Participation in May Investor Conferences

    Versigent PLC (NYSE:VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after market close. Versigent will host a conference call to discuss the results at 4:15 p.m. Eastern Time the same day. The conference call will be hosted by Versigent's Chief Executive Officer, Joe Liotine, and Chief Financial Officer, Doug Ostermann. A link to the live webcast and presentation materials will be made available on the Versigent Investor Relations website at ir.versigent.com. A replay will be available two hours following the conference call. To p

    4/21/26 2:03:00 PM ET
    $VGNT

    $VGNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Vinci Sharon

    4 - Versigent PLC (0002078008) (Issuer)

    4/6/26 9:06:36 PM ET
    $VGNT

    SEC Form 4 filed by Ostermann Douglas R

    4 - Versigent PLC (0002078008) (Issuer)

    4/6/26 9:04:41 PM ET
    $VGNT

    SEC Form 4 filed by Celian Jason

    4 - Versigent PLC (0002078008) (Issuer)

    4/6/26 9:04:17 PM ET
    $VGNT

    $VGNT
    Financials

    Live finance-specific insights

    View All

    Versigent Announces First Quarter 2026 Earnings Call and Participation in May Investor Conferences

    Versigent PLC (NYSE:VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after market close. Versigent will host a conference call to discuss the results at 4:15 p.m. Eastern Time the same day. The conference call will be hosted by Versigent's Chief Executive Officer, Joe Liotine, and Chief Financial Officer, Doug Ostermann. A link to the live webcast and presentation materials will be made available on the Versigent Investor Relations website at ir.versigent.com. A replay will be available two hours following the conference call. To p

    4/21/26 2:03:00 PM ET
    $VGNT